🇺🇸 Magnesium sulfate IV in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Acidosis — 1 report (10%)
2. Acute Respiratory Failure — 1 report (10%)
3. Amnesia — 1 report (10%)
4. Body Temperature Increased — 1 report (10%)
5. Cough — 1 report (10%)
6. Drooling — 1 report (10%)
7. Dyspnoea — 1 report (10%)
8. Hypertension — 1 report (10%)
9. Hypoxia — 1 report (10%)
10. Memory Impairment — 1 report (10%)

Source database →

Frequently asked questions

Is Magnesium sulfate IV approved in United States?

Magnesium sulfate IV does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Magnesium sulfate IV in United States?

University of Liege is the originator. The local marketing authorisation holder may differ — check the official source linked above.